Littleton Regional Healthcare’s Post

Molecular Diagnostics Devices And Equipment Market worth $48.38 Billion by 2028 Global molecular diagnostics devices and equipment market size is expected to reach $48.38 Bn by 2028 at a rate of 8.6%, segmented as by product, instruments, reagents and consumables, software Read more https://lnkd.in/gF_4JHWE #marketresearch #marketreport

Selecting right hematology analyzer is crucial for optimizing lab efficiency and accuracy. Considering both price and performance ensures cost-effectiveness without compromising diagnostic quality for long-term lab management and growth. Check: https://lnkd.in/dWCi3_Ji #HematologyAnalyzer #HematologyAnalyzers #Hematology #CBCMachine #CBCTest #BloodTest #PathologyTest #PathologyLabTest #LabTest #Labtesting #BloodTesting #PathologyLab #Lab #drlogy #drlogyplus #BloodAnalyzer #PathologyLabMachine #LabMachines #LabEquipment #PathologyLabEquipment #laboratory #doctors #doctor #diagnostics #diagnostic #diagnosticservices #Cbc #cbctest

【All-in-One Hematology Solution _Total Automation for Optimal Workflow】 High reagent replacement frequency and storage has been a challenge in laboratories, which can now be addressed by Mindray's CR-30 Concentrated Reagent Delivery System. By using concentrated reagents, CR-30 reduces costs and tackles challenges associated with handling large volumes. Designed to integrate with the CAL series cellular analysis lines, it helps improve efficiency and reduce risks in laboratory operations. #LaboratoryAutomation #MindrayAllinOneSolution #MindrayHematology

【All-in-One Hematology Solution _Total Automation for Optimal Workflow】 High reagent replacement frequency and storage have been a challenge in laboratories, which can now be addressed by Mindray's CR-30 Concentrated Reagent Delivery System. By using concentrated reagents, CR-30 reduces costs and tackles challenges associated with handling large volumes. Designed to integrate with the CAL series cellular analysis lines, it helps improve efficiency and reduce risks in laboratory operations. #LaboratoryAutomation #MindrayAllinOneSolution #MindrayHematology

Perfect Solution

The National Medical Products Administration (NMPA) of China has released Notification No. 17 of 2024, introducing the "Catalogue of In Vitro Diagnostic Reagent Classification." This initiative is designed to streamline the classification process for in vitro diagnostic reagents as per the "Regulations on the Supervision and Management of Medical Devices" and other related guidelines. The Catalogue delineates the scope and structure of these reagents, excluding those used for legally mandated blood screening and those labeled with radioactive isotopes, and organizes them into a detailed system of 25 first-level and 1,852 second-level categories based on detection targets. It provides a pathway for the management of new products, allowing for direct Class III registration or category determination under the Classification Rules. The notification also specifies the management of various products including culture and cell culture media, and general reagents. Moreover, it announces the repeal of previous related notices, effective January 1, 2025, and highlights the dynamic adjustment of the Catalogue based on ongoing risk analysis and device evaluation. This systematic update aims to ensure regulatory compliance and facilitate the registration and filing processes for in vitro diagnostic reagents.

Selecting the right hematology analyzer (CBC Machine) supplier is critical for ensuring accurate diagnoses and efficient laboratory operations. Know Expert's Guide. Check: https://lnkd.in/dw6_i-RC #HematologyAnalyzer #HematologyAnalyzers #Hematology #CBCMachine #CBCTest #BloodTest #PathologyTest #PathologyLabTest #LabTest #Labtesting #BloodTesting #PathologyLab #Lab #drlogy #drlogyplus #BloodAnalyzer #PathologyLabMachine #LabMachines #LabEquipment #PathologyLabEquipment #laboratory #doctors #doctor #diagnostics #diagnostic #diagnosticservices #Cbc #cbctest

Chemiluminescence Immunoassay Analyzer: Introduction and Top 4 Picks Click the link to read the full article: https://lnkd.in/dMAKsyyT #immunoassay #chemiluminescence #pointofcare #invitrodiagnostics #medicaldiagnostics #medicaldevices

Hematology Diagnostics Market Focused Insights 2024-2029, with Coverage of Industry Leaders Abbott, Sysmex, Danaher, Boule Diagnostics, HORIBA, Siemens Healthineers, Nihon Kohden and Diatron - ResearchAndMarkets.com DUBLIN--(BUSINESS WIRE)--The "Hematology Diagnostics Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Hematology Diagnostics Market was valued at USD 3.87 billion in 2023, and is expected to reach USD 5.12 billion by 2029, rising at a CAGR of 4.78%. The global hematology diagnostics market report consists of exclusive data on 42 vendors. The market is characterized by a variety of global and local players, including industry leaders such as Ab via Business Wire Health: Medical Devices News

Source: The journal of applied laboratory medicine A study evaluated the use of a busulfan immunoassay on the Abbott Alinity c platform for therapeutic drug monitoring (TDM). The immunoassay showed good performance and correlation with liquid chromatography-mass spectrometry (LC-MS/MS) and another clinical chemistry analyzer. This verification allows for busulfan TDM to be performed on a routine clinical chemistry analyzer, improving turnaround times and patient outcomes.